EUVIMEDEUVIMED entdecken
Crossref

Survival Impact of Immunotherapy in Advanced Head and Neck Squamous Cell Carcinoma: A National Cancer Database Analysis

Rohan Vuppala iD, Sallie Long, Daniel Sharbel, Forest Weir

Head & Neck · 2025

DOI: 10.1002/hed.70140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Rohan Vuppala und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical College of Georgia, Augusta, Georgia, USA. Hauptthemen laut MEDLINE: Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Immunotherapy. Die Arbeit nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We evaluated the association between immunotherapy (IO) and overall survival (OS) in advanced head and neck squamous cell carcinoma (HNSCC) and examined outcomes by IO timing.

Methods

Retrospective cohort study of national NCDB 2004–2022 United States adults with Stages III–IVB HNSCC. Exposure was any IO. The primary outcome was OS from diagnosis; analyses used multivariable Cox models, 24‐month landmarking, and propensity methods.

Results

Among 221 116 patients (mean age: 62), 10 023 (4.5%) received IO. Median follow‐up 37 months. IO was associated with lower mortality (HR: 0.91; 95% CI: 0.89–0.94). Landmark analysis showed benefit 0–24 months (HR: 0.76; 0.74–0.79) that reversed thereafter (HR: 1.09; 1.04–1.14). By intent, median OS was 53.2 months (neoadjuvant), 50.1 months (adjuvant), 16.5 months (later‐line), versus 60.7 months without IO. Propensity analyses attenuated effects (HR: ~1.00).

Conclusions

In real‐world advanced HNSCC, IO confers modest early benefit with varied long‐term results; outcomes vary by timing. Prospective biomarker‐stratified trials are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Squamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsImmunotherapyHumansMaleFemaleRetrospective StudiesMiddle AgedUnited StatesDatabases, FactualAgedSurvival AnalysisNeoplasm StagingAdult

Stichwörter der Autor:innen

National Cancer Databasehead and neck squamous cell carcinomaimmune checkpoint inhibitorslandmark analysisoverall survival

Autor:innen und Institutionen

  • Medical College of Georgia, Augusta, Georgia, USA.
  • Department of Otolaryngology-Head and Neck Surgery, Medical College of Georgia, Augusta, Georgia, USA.

ORCID-Profile: Rohan Vuppala

Zitieren

APA

Vuppala, R., Long, S., Sharbel, D., & Weir, F. (2025). Survival Impact of Immunotherapy in Advanced Head and Neck Squamous Cell Carcinoma: A National Cancer Database Analysis. Head & Neck. https://doi.org/10.1002/hed.70140

Vancouver

Vuppala R, Long S, Sharbel D, Weir F. Survival Impact of Immunotherapy in Advanced Head and Neck Squamous Cell Carcinoma: A National Cancer Database Analysis. Head & Neck. 2025. doi:10.1002/hed.70140

BibTeX
@article{Vuppala2025,
  author = {Vuppala, Rohan and Long, Sallie and Sharbel, Daniel and Weir, Forest},
  title = {Survival Impact of Immunotherapy in Advanced Head and Neck Squamous Cell Carcinoma: A National Cancer Database Analysis},
  journal = {Head & Neck},
  year = {2025},
  doi = {10.1002/hed.70140}
}
Kostenlos starten →